OZURDEX (dexamethasone intravitreal implant) is indicated for the treatment of adult patients with macular edema due to Branch Retinal Vein Occlusion (BRVO) or Central Retinal Vein Occlusion (CRVO).
OZURDEX is indicated for the treatment of non-infectious uveitis affecting the posterior segment of the eye.
OZURDEX is indicated for the treatment of diabetic macular edema.